OpenVSafe by OpenVAERS
Search V-safe

JG2-13252-17216

2 vaccinations 2 coded responses 15 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
714 / LA
Registered
2021-04-13
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-30
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-13
    Registered in v-safe
  3. 2021-04-13
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-04-20
    Dose 2 — Pfizer-BioNTech
  5. 2021-04-20
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-04-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-05-04
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-05-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-06-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-07-20
    Survey response — 3 months, dose 2
    MedDRA: Nasal congestion, Oropharyngeal pain, Paranasal sinus hypersecretion — Feeling: Fair
    Free text: Sore throat, nasal congestion, sinus drainage
    MedDRA releases: 2024-11 · check-in free text available
  17. 2021-10-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-04-20
    Survey response — 12 months, dose 2
    MedDRA: Hyperthyroidism, Illness, Pre-existing disease, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Lots of random things. Tachycaria, shbclinical hyperthyroidism, lots of illness and allergies.
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-04-20
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  20. 2022-04-22

Vaccinations

DoseDateManufacturerCo-administered
12021-03-30Pfizer-BioNTech
22021-04-20Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-07-20

Symptoms: Sore throat, nasal congestion, sinus drainage

Release 11 — 12 months, dose 2

2022-04-20

Symptoms: Lots of random things. Tachycaria, shbclinical hyperthyroidism, lots of illness and allergies.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHyperthyroidism · · ✓
SDIllness · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDParanasal sinus hypersecretion · · ✓
SDPre-existing disease · · ✓
SDTachycardia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release